3-iodobenzylguanidine has been researched along with etoposide in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boneu, A; Hartmann, O; Hattchouel, JM; Lumbroso, J; Robert, A; Rodary, C; Rubie, H; Suc, A | 1 |
| Bonneu, A; Chauvot, P; Edeline, V; Frappaz, D; Giammarile, F; Gomez, F; Siles, S; Wioland, M | 1 |
| Diociaiuti, L; Mastrangelo, R; Mastrangelo, S; Pession, A; Prete, A; Rufini, V; Tornesello, A; Troncone, L | 1 |
| Berthold, F; Gahr, M; Hero, B; Hunneman, DH | 1 |
| Cole, M; Ellershaw, C; Lewis, IJ; Pearson, AD; Pinkerton, CR; Tweddle, DA | 1 |
| Braun, T; Ferrara, JL; Hubers, D; Hutchinson, RJ; Levine, JE; Matthay, KK; Shapiro, B; Shulkin, BL; Sisson, JC; Spalding, S; Yanik, GA | 1 |
| Cheung, NK; Kramer, K; Kushner, BH; Larson, SM; Yeh, SD | 1 |
| Bergeron, C; Bernard, F; Boneu, A; Bouzy, J; Chastagner, P; Coze, C; Hartmann, O; Michon, J; Perel, Y; Plantaz, D; Rodary, C; Rubie, H; Valteau-Couanet, D | 1 |
| Franc, B; Groshen, S; Horn, B; Maris, JM; Matthay, KK; Reynolds, CP; Seeger, RC; Tan, JC; Twomey, E; Veatch, J; Villablanca, JG; Yanik, GA | 1 |
| Aoyama, C; Hosoya, R; Kamiya, T; Kato, I; Manabe, A; Ogawa, C; Ozawa, M; Takahashi, H; Takusagawa, A; Yokoyama, K | 1 |
| Akhurst, TJ; Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Di Giannatale, A; Mastrangelo, S; Riccardi, R; Rufini, V; Ruggiero, A | 1 |
| Basu, EM; Cheung, NK; Kramer, K; Kushner, BH; Modak, S; Roberts, SS | 1 |
| Behfar, M; Beiki, D; Eftekhari, M; Fallahi, B; Fard-Esfahani, A; Ghavamzadeh, A; Hamidieh, AA; Hosseini, AS; Paragomi, P; Shamshiri, A | 1 |
| Allen-Rhoades, W; Kim, E; Krance, R; Louis, CU; Mazloom, A; Nuchtern, J; Paulino, AC; Russell, H | 1 |
| Cho, EJ; Cho, HW; Koo, HH; Lee, JW; Lee, S; Lee, SK; Lim, DH; Ma, Y; Sung, KW; Yoo, KH | 1 |
7 trial(s) available for 3-iodobenzylguanidine and etoposide
| Article | Year |
|---|---|
Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Infusions, Intravenous; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Neuroblastoma; Radiopharmaceuticals; Treatment Outcome; Vincristine | 2001 |
Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Homovanillic Acid; Humans; Ifosfamide; Iodine Radioisotopes; Life Tables; Melphalan; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vanilmandelic Acid; Vincristine; Vindesine | 2001 |
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Diphosphonates; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Incidence; Infant; Iodine Radioisotopes; Kidney Diseases; Male; Neoplasm Staging; Nervous System Diseases; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Survival Analysis; Survival Rate; Technetium Compounds; Treatment Outcome; Vincristine | 2001 |
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Transplantation, Autologous | 2002 |
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neuroblastoma; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2006 |
Incorporation of high-dose
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Induction Chemotherapy; Infant; Melphalan; Neuroblastoma; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous; Young Adult | 2017 |
9 other study(ies) available for 3-iodobenzylguanidine and etoposide
| Article | Year |
|---|---|
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neuroblastoma; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed | 1996 |
Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Forecasting; Humans; Infant; Multicenter Studies as Topic; Neuroblastoma; Observer Variation; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Retrospective Studies; Statistics as Topic; Treatment Outcome | 2000 |
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Catecholamines; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Risk | 2003 |
Iodine-131-metaiodobenzylguanidine therapy with reduced-intensity allogeneic stem cell transplantation in recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Camptothecin; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Iodine Radioisotopes; Irinotecan; Neuroblastoma; Recurrence; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 2008 |
A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Dura Mater; Etoposide; Femur; Humans; Infant; Iodine Radioisotopes; Male; Meningeal Neoplasms; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Remission Induction; Skin Neoplasms | 2009 |
Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Male; Neuroblastoma; Pilot Projects; Radiopharmaceuticals; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2011 |
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Male; Neuroblastoma; Outpatients; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Temozolomide | 2013 |
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Prognosis; Prospective Studies; Radionuclide Imaging; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Infant; Neoplasm, Residual; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Young Adult | 2014 |